Saturn V Capital Management LLC Chinook Therapeutics, Inc. Transaction History

Saturn V Capital Management LLC

  • $265 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$18.66 - $38.58 $335,749 - $694,169
17,993 Added 3.55%
524,811 $20.2 Billion
Q1 2023

May 15, 2023
BUY
$21.53 - $26.8 $1.8 Million - $2.24 Million
83,641 Added 19.77%
506,818 $11.7 Billion
Q4 2022

Feb 09, 2023
BUY
$18.63 - $27.35 $7.88 Million - $11.6 Million
423,177 New
423,177 $6.73 Billion

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email